Overview

Phase III Trial of Febuxostat in Korea Gout Patients

Status:
Completed
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
This study was designed to evalute the efficacy and safety of Febuxostat after oral administration to patientd with gout in Korea
Phase:
Phase 3
Details
Lead Sponsor:
SK Chemicals Co., Ltd.
SK Chemicals Co.,Ltd.
Treatments:
Allopurinol
Febuxostat